|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2823 USD | +2.51% |
|
+4.56% | -88.04% |
| May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
GlycoMimetics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 10.74 million compared to USD 10.36 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.17 a year ago.
Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -88.04% | 18.19M | |
| +9.99% | 115B | |
| +12.01% | 106B | |
| -3.07% | 24.69B | |
| -0.99% | 21.97B | |
| -5.01% | 19.27B | |
| -6.90% | 17.56B | |
| -39.36% | 17.32B | |
| +5.82% | 14.03B | |
| +33.05% | 12.13B |
GLYCOMIMETICS, INC. 
